skip to Main Content

Humana December 2017 Pharmacy Policy Updates

Click here to view the Humana Pharmacy Policy Updates »

December 2017 Pharmacy Policy Updates

Policy Name Reviewed Date
Naftin® Gel (naftifine) 12/28/2017
Hemlibra® (emicizumab-kxwh) 12/21/2017
GLP-1 Analogs 12/14/2017
GLP-1 Analogs 12/14/2017
Nuedexta® (dextromethorphan and quinidine) 12/14/2017
Nuedexta® (dextromethorphan and quinidine) 12/14/2017
Opioid Utilization Program – Morphine equivalent dose (MED) edits 12/14/2017
Opioid Utilization Program – Morphine equivalent dose (MED) edits 12/14/2017
Afrezza® (insulin human) Inhalation Powder 12/13/2017
Aliqopa™ (copanlisib) 12/13/2017
Alpha-1 Proteinase Inhibitors (Aralast NP®, Glassia®) 12/13/2017
Alpha-1 Proteinase Inhibitors (Prolastin-C®, Zemaira®) 12/13/2017
Anzemet® (dolasetron) 12/13/2017
Arcalyst® (rilonacept) 12/13/2017
Atgam® (antithymocyte immune globulin, equine) 12/13/2017
Auvi-Q® (epinephrine injection) 12/13/2017
Azopt® (brinzolamide ophthalmic suspension) 1% 12/13/2017
Biguanide Agents 12/13/2017
Cayston® (aztreonam inhalation solution) 12/13/2017
Cytogam® (cytomegalovirus immune globulin, human) 12/13/2017
Darzalex® (daratumumab) 12/13/2017
Fusilev® (levoleucovorin) 12/13/2017
Fycompa® (perampanel) 12/13/2017
Gocovri™ (amantadine) 12/13/2017
High Risk Medications (HRM) in the Elderly 12/13/2017
Idiopathic Pulmonary Fibrosis Products (Ofev, Esbriet) 12/13/2017
Ilaris® (canakinumab) 12/13/2017
Iluvien® (fluocinolone acetonide intravitreal implant) 12/13/2017
Intron A® (interferon alfa-2b) 12/13/2017
Istodax® (romidepsin) 12/13/2017
Jakafi® (ruxolitinib) 12/13/2017
Lartruvo™ (olaratumab) 12/13/2017
Minocycline Extended Release 12/13/2017
Movantik® (naloxegol) 12/13/2017
Namenda® (memantine HCl) and Namenda XR® (memantine HCl extended-release) 12/13/2017
Nplate® (romiplostim) 12/13/2017
Oral Acne Antibiotics 12/13/2017
Osphena® (ospemifene) 12/13/2017
Otrexup ™ (methotrexate injection) 12/13/2017
Pomalyst® (pomalidomide) 12/13/2017
Prestalia® (perindopril-amlodipine) 12/13/2017
Promacta® (eltrombopag) 12/13/2017
Rapid-Acting Fentanyl (Abstral®, Actiq®, Fentora®, Lazanda®, Subsys®) 12/13/2017
Rayaldee® (calcifediol) 12/13/2017
Sandostatin® S.C., Sandostatin LAR® Depot (octreotide acetate for injection) 12/13/2017
Sandostatin® S.C., Sandostatin LAR® Depot (octreotide acetate for injection) 12/13/2017
Savaysa® (edoxaban) 12/13/2017
Sernivo™ (betamethasone dipropionate) Spray 12/13/2017
Sernivo™ (betamethasone dipropionate) Spray 12/13/2017
Signifor® LAR (pasireotide) 12/13/2017
Simbrinza™ (brinzolamide/brimonidine ophthalmic suspension) 12/13/2017
Simponi® (golimumab) 12/13/2017
Simponi® (golimumab) 12/13/2017
Soliqua™ 100/33 (insulin glargine and lixisenatide) 12/13/2017
Soliris® (eculizumab) 12/13/2017
Somatuline Depot® (lanreotide) 12/13/2017
Somavert® (pegvisomant) 12/13/2017
Soolantra® (ivermectin 1% topical cream) 12/13/2017
Supprelin® LA (histrelin acetate implant) 12/13/2017
Supprelin® LA (histrelin acetate implant) 12/13/2017
Symproic® (naldemedine) 12/13/2017
Taclonex® (calcipotriene and betamethasone dipropionate) 12/13/2017
Thymoglobulin® (anti-thymocyte globulin [rabbit]) 12/13/2017
Topical Rosacea Products 12/13/2017
Topical Tretinoin Containing Products 12/13/2017
Tracleer (bosentan) tablet for oral suspension 12/13/2017
Trelegy Ellipta® (fluticasone furoate, umeclidinium, vilanterol) 12/13/2017
Trulance™(plecanatide) 12/13/2017
Uceris® Tablet and Rectal Foam (budesonide) 12/13/2017
Varizig® (varicella zoster immune globulin) 12/13/2017
Varubi® (rolapitant) 12/13/2017
Venclexta™ (venetoclax) 12/13/2017
Verzenio™ (abemaciclib) 12/13/2017
Vimpat® (lacosamide) 12/13/2017
Xultophy® 100/3.6 (insulin degludec and liraglutide) 12/13/2017
Yescarta™ (axicabtagene ciloleucel) 12/13/2017
Yondelis® (trabectedin) 12/13/2017
Zilretta™ (triamcinolone acetonide extended-release injectable suspension) 12/13/2017
Zometa® (zoledronic acid) 12/13/2017
Zontivity® (vorapaxar) 12/13/2017
Mepsevii™ (vestronidase alfa-vjbk) 12/7/2017
Ophthalmic Prostaglandins 12/7/2017
Ophthalmic Prostaglandins 12/7/2017
Actimmune® (interferon gamma-1b)

 

Click here to view the Humana Pharmacy Policy Updates »

 

Policy Alerts monitors Commercial and Medicare medical policies for changes. While Payers typically update medical policies annually, there are many reasons why a Payer might review or update a policy. When reviews occur out of cycle, they may go unnoticed. Policy Alerts keeps you informed of upcoming and unexpected coverage changes affecting your product. Quickly understanding the changes Payers make can help you adjust reimbursement strategies impacting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on Payer decisions in real-time. Whenever changes occur, email notifications containing a summary of those changes are delivered to your inbox. Clients can access detailed coverage reports and medical policies on the interactive Dashboard portal. Save time and keep focused on the important Payer medical policy reviews and coverage decisions affecting your product!

Policy Alerts takes a client-focused hands-on approach and works hard to provide our customers with helpful insights and actionable analytics over raw data. We understand what our clients need and we are dedicated to making sure we provide timely, accurate and always up-to-date reports that can be used to implement and support a successful reimbursement strategy.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.

This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Back To Top